CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 34 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,723 | -100.0% | 23,616,000 | 0.0% | 0.13% | -45.1% |
Q3 2022 | $16,885,000 | 0.0% | 23,616,000 | 0.0% | 0.24% | -38.4% |
Q2 2022 | $16,885,000 | -10.1% | 23,616,000 | -5.0% | 0.38% | -11.9% |
Q1 2022 | $18,774,000 | +8.6% | 24,866,000 | 0.0% | 0.44% | +15.9% |
Q4 2021 | $17,282,000 | +9.1% | 24,866,000 | +2.1% | 0.38% | -10.0% |
Q3 2021 | $15,838,000 | -12.4% | 24,366,000 | 0.0% | 0.42% | -16.4% |
Q2 2021 | $18,076,000 | -21.0% | 24,366,000 | -19.0% | 0.50% | -45.1% |
Q1 2021 | $22,875,000 | -33.4% | 30,066,000 | -38.1% | 0.91% | -30.7% |
Q4 2020 | $34,360,000 | +10.7% | 48,566,000 | +4.3% | 1.32% | -21.3% |
Q3 2020 | $31,025,000 | +43.3% | 46,566,000 | +30.9% | 1.67% | -9.2% |
Q2 2020 | $21,651,000 | +92.4% | 35,566,000 | +96.9% | 1.84% | +53.0% |
Q1 2020 | $11,252,000 | -7.2% | 18,066,000 | -5.2% | 1.20% | -10.1% |
Q4 2019 | $12,121,000 | +162.1% | 19,066,000 | +72.3% | 1.34% | +98.5% |
Q3 2019 | $4,625,000 | -63.5% | 11,066,000 | -38.5% | 0.68% | +80.5% |
Q4 2018 | $12,670,000 | – | 18,000,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antara Capital LP | 55,678,000 | $42,628,000 | 3.59% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,066,000 | $22,875,000 | 0.91% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 29,000,000 | $21,750,000,000 | 0.31% |
FARALLON CAPITAL MANAGEMENT LLC | 51,910,000 | $39,243,000 | 0.20% |
OAKTREE CAPITAL MANAGEMENT LP | 6,349,000 | $4,860,000 | 0.07% |
Psagot Value Holdings Ltd. | 1,500,000 | $1,141,000 | 0.03% |
Allianz Asset Management GmbH | 29,945,000 | $22,766,000 | 0.02% |
D. E. Shaw & Co., Inc. | 25,050,000 | $19,155,000 | 0.02% |
AMERIPRISE FINANCIAL INC | 42,200,000 | $31,887,000 | 0.01% |
PALISADE CAPITAL MANAGEMENT, LP | 330,000 | $250,000 | 0.01% |